MolPort-002-051-367

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers, 8 USDMF, 4 CEP/COS, 2 JDMF, 5 EU WC, 1 KDMF, 7 NDC API, 5 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

DOSSIERs // Finished Dosage Forms

144 Dossiers, 118 FDA Orange Book, 2 Europe, 4 Canada, 4 South Africa, 16 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 5MG;2.5MG, CAPSULE;ORAL - 5MG, CAPSULE;ORAL - 10MG, CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 23 BASF, 16 Roquette, 12 Microlex e.U, 11 Sigachi Industries, 10 Corel Pharma Chem, 8 Gangwal Healthcare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Seppic, 7 Gangwal Chemicals, 6 Lonza Capsugel, 6 DFE Pharma, 5 Ideal Cures Pvt Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 SPI Pharma, 4 ACG Worldwide, 3 Nanjing Well Pharmaceutical, 3 Vasa Pharmachem, 3 Actylis, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 3 Prachin Chemical, 2 The Dow Chemical Company, 2 Qualicaps, 2 Nomisma Healthcare, 2 Pharmatrans-Sanaq, 2 Seqens, 2 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Ulanqab Kema New Material, 1 Jai Radhe Sales, 1 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 30 Direct Compression, 30 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 22 Granulation, 18 Thickeners and Stabilizers, 14 Solubilizers, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 10 Topical, 10 Film Formers & Plasticizers, 9 Empty Capsules, 9 Taste Masking, 7 Parenteral, 6 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 2 Coloring Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 5 Finished Drug Prices

MARKET PLACE

18 APIs, 1 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

1 EDQM Standards, 3 USP Standards, 5 JP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

12 News

12 News

Approved Drug Products containing MolPort-002-051-367 listed with Health Canada. Original Data : Health Canada Website

MolPort-002-051-367

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

14 Suppliers

8 USDMF

4 CEP/COS

2 JDMF

5 EU WC

1 KDMF

7 NDC API

5 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

DOSSIERs // Finished Dosage Forms

144 Dossiers

118 FDA Orange Book

2 Europe

4 Canada

4 South Africa

16 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 5MG;2.5MG

CAPSULE;ORAL - 5MG

CAPSULE;ORAL - 10MG

CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

Suppliers

37 Kerry

23 BASF

16 Roquette

12 Microlex e.U

11 Sigachi Industries

10 Corel Pharma Chem

8 Gangwal Healthcare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Seppic

7 Gangwal Chemicals

6 Lonza Capsugel

6 DFE Pharma

5 Ideal Cures Pvt Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 SPI Pharma

4 ACG Worldwide

3 Nanjing Well Pharmaceutical

3 Vasa Pharmachem

3 Actylis

3 Ingredion Pharma Solutions

3 Kima Chemical

3 Prachin Chemical

2 The Dow Chemical Company

2 Qualicaps

2 Nomisma Healthcare

2 Pharmatrans-Sanaq

2 Seqens

2 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

1 Ulanqab Kema New Material

1 Jai Radhe Sales

1 DKSH

1 Boai NKY Pharmaceuticals Ltd

1 Aeon Procare

EXCIPIENTS BY APPLICATIONS

63 Fillers, Diluents & Binders

46 Coating Systems & Additives

30 Direct Compression

30 Controlled & Modified Release

22 Disintegrants & Superdisintegrants

22 Granulation

18 Thickeners and Stabilizers

14 Solubilizers

14 Lubricants & Glidants

12 Co-Processed Excipients

10 Topical

10 Film Formers & Plasticizers